Provided are protease inhibitor compounds that find use in treating or preventing coronavirus disease. In some embodiments, the coronavirus disease is COVID-19. Also provided are compositions and kits comprising the compounds, as well methods of using the compounds to treat or prevent coronavirus disease. Methods of assessing inhibition of coronavirus protease activity by an agent are also provided.
提供了蛋白酶抑制剂化合物,可用于治疗或预防冠状病毒疾病。在某些实施例中,冠状病毒疾病是COVID-19。还提供了包含这些化合物的组合物和试剂盒,以及使用这些化合物治疗或预防冠状病毒疾病的方法。还提供了评估代理物抑制冠状病毒
蛋白酶活性的方法。